iCAD, Inc. (iCAD) is an advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies and the most prevalent cancers. The Company has two reportable segments Cancer Detection (Detection) and Cancer Therapy. The Detection segment consists of its advanced image analysis and workflow products offering a comprehensive range of high-performance, upgradeable Computer-Aided Detection (CAD) systems and workflow solutions for mammography, Magnetic Resonance Imaging (MRI) and Computed Tomography CT. In the Therapy segment consists of its radiation therapy (Axxent) products, physics and management services, development fees, supplies, and the right to use the AxxentHub software platform. It offers an isotope-free cancer treatment platform technology. The Xoft Electronic Brachytherapy System (Xoft eBx) can be used for the treatment of early- stage breast cancer, endometrial cancer, cervical cancer and skin cancer.